« Previous
Next »
Titles
- ANDA submissions--amendments to abbreviated new drug applications under GDUFA1
- Acne vulgaris: establishing effectiveness of drugs intended for treatment1
- Adolescent and young adult substance use: federal grants for prevention, treatment, and recovery services and for research : report to Congressional committees1
- Allergic rhinitis: developing drug products for treatment1
- Anthrax: developing drugs for prophylaxis of inhalational anthrax1
- Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff1
- Assessing user fees under the Prescription Drug User Fee Amendments of 20171
- Assessing user fees under the biosimilar user fee amendments of 20171
- Assessment and synthesis of selected Medicaid eligibility, enrollment, and renewal processes and systems in six states1